Novo Nordisk - ADR NVO

Dividend Summary

The next Novo Nordisk - ADR dividend is expected to go ex in 3 months and to be paid in 4 months.
The previous Novo Nordisk - ADR dividend was 51.69c and it went ex 4 months ago and it was paid 4 months ago.
There are typically 2 dividends per year (excluding specials).

Latest Dividends

Summary	Previous dividend	Next dividend
Status	Paid	Forecast
Type	Interim	Final
Per share	51.69c	Sign Up Required
Declaration date	06 Aug 2024 (Tue)	–
Ex-div date	16 Aug 2024 (Fri)	24 Mar 2025 (Mon)
Pay date	26 Aug 2024 (Mon)	08 Apr 2025 (Tue)

Enter the number of Novo Nordisk - ADR shares you hold and we'll calculate your dividend payments:

Previous Payment

$51.69

Paid on 26 Aug 2024 (Mon)

Next Payment

Paid on 08 Apr 2025 (Tue)

Forecast Accuracy

99%

Our premium tools have predicted Novo Nordisk - ADR with 99% accuracy.

Try Premium

Dividend Yield Today

1.9%

The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price

Free Email Notification

Add Novo Nordisk - ADR to receive free notifications when they declare their dividends.

Your account is set up to receive Novo Nordisk - ADR notifications.

Manage notifications

The table below shows the full dividend history for Novo Nordisk - ADR

Status	Type	Decl. date	Ex-div date	Pay date	Decl. Currency	Forecast amount	Decl. amount	Accuracy
Forecast	Final	–	26 Mar 2029	03 Apr 2029	USD	Sign up	—
Forecast	Interim	–	18 Aug 2028	21 Aug 2028	USD	Sign up	—
Forecast	Final	–	27 Mar 2028	04 Apr 2028	USD	Sign up	—
Forecast	Interim	–	13 Aug 2027	23 Aug 2027	USD	Sign up	—
Forecast	Final	–	29 Mar 2027	06 Apr 2027	USD	Sign up	—
Forecast	Interim	–	14 Aug 2026	24 Aug 2026	USD	Sign up	—
Forecast	Final	–	30 Mar 2026	07 Apr 2026	USD	Sign up	—
Forecast	Interim	–	15 Aug 2025	25 Aug 2025	USD	Sign up	—
Forecast	Final	–	24 Mar 2025	08 Apr 2025	USD	Sign up	—
Paid	Interim	06 Aug 2024	16 Aug 2024	26 Aug 2024	USD	—	51.69c
Paid	Final	31 Jan 2024	22 Mar 2024	02 Apr 2024	USD	93.1c	92.93c	😄
Paid	Interim	10 Aug 2023	18 Aug 2023	29 Aug 2023	USD	72.18c	72.18c	😄
Paid	Final	02 Feb 2023	24 Mar 2023	04 Apr 2023	USD	114.62c	118.06c	😃
Paid	Interim	04 Aug 2022	12 Aug 2022	23 Aug 2022	USD	—	57.77c
Paid	Final	02 Mar 2022	25 Mar 2022	05 Apr 2022	USD	—	102.24c
Paid	Interim	–	16 Aug 2021	25 Aug 2021	USD	—	55.03c
Paid	Final	–	26 Mar 2021	07 Apr 2021	USD	—	92.21c
Paid	Interim	06 Aug 2020	14 Aug 2020	25 Aug 2020	USD	—	51.78c
Paid	Final	06 Feb 2020	27 Mar 2020	07 Apr 2020	USD	—	78.26c
Paid	Interim	09 Aug 2019	16 Aug 2019	27 Aug 2019	USD	—	44.94c
Paid	Final	26 Mar 2019	22 Mar 2019	02 Apr 2019	USD	—	77.7c
Paid	Interim	21 Aug 2018	17 Aug 2018	28 Aug 2018	USD	—	46.23c
Paid	Final	–	23 Mar 2018	03 Apr 2018	USD	—	80.6c
Paid	Interim	–	17 Aug 2017	29 Aug 2017	USD	—	47.38c
Paid	Final	–	23 Mar 2017	04 Apr 2017	USD	—	67.04c
Paid	Interim	–	11 Aug 2016	23 Aug 2016	USD	—	45.35c
Paid	Final	23 Mar 2016	18 Mar 2016	30 Mar 2016	USD	—	95.81c
Paid	Final	10 Feb 2015	19 Mar 2015	31 Mar 2015	USD	—	73c
Paid	Final	13 Mar 2014	21 Mar 2014	02 Apr 2014	USD	—	83.03c
Paid	Final	26 Feb 2013	21 Mar 2013	02 Apr 2013	USD	—	310.18c

Year	Amount	Change
2006	0.0c	—
2007	0.0c	 0%
2008	0.0c	 0%
2009	0.0c	 0%
2010	0.0c	 0%
2011	0.0c	 0%
2012	310.18c	 100%
2013	83.03c	 -73.2%
2014	73.0c	 -12.1%
2015	95.81c	 31.2%
2016	112.39c	 17.3%
2017	127.98c	 13.9%
2018	123.93c	 -3.2%
2019	123.2c	 -0.6%
2020	143.99c	 16.9%
2021	157.27c	 9.2%
2022	175.83c	 11.8%
2023	165.11c	 -6.1%
2024	Sign Up Required
2025	Sign Up Required
2026	Sign Up Required
2027	Sign Up Required
2028	Sign Up Required

Novo Nordisk Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.

Dividend Yield Today: 1.9%
Optimized Yield: Sign Up Required
52 Week High: 2.8% on 22 December 2024
52 Week Low: 1.3% on 16 August 2024
Next Ex-Div-Date Countdown: Sign Up Required

About Novo Nordisk

Novo Nordisk is a pharmaceutical company focussed on diabetes treatment. It also operates in haemostasis management, growth hormone therapy and hormone replacement therapy. It employs over 26,000 people across 79 countries and markets its products in 180 countries.

Sector: Pharmaceuticals & Biotechnology
Country: United States
Share Price: $85.00 (yesterday's closing price)
Shares in Issue: 3,390 million
Market Cap: $288.2bn
CADI The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends: 0
Market Indices: none
Other listings: Novo Nordisk, Novo Nordisk - Class B Shares
Investor Relations URL: Sign Up Required
Home Page URL: https://www.novonordisk.com/
Dividend History URL: Sign Up Required
Financial Calendar URL: Sign Up Required

Matthew Riding

DividendMax Limited

https://cdn.dividendmax.com/assets/dividendmax-logo-69fb3a77a84cafdd3c25b46bcb112fc0bc5f3767d1c22ca1cbbae5f7cf9fb091.png

2023-09-02 00:44:47

Effectiveness and Issues of Celebrity Endorsement in Global Pharmaceutical Industry: Novo Nordisk Case Celebrity endorsement in the global pharmaceutical industry has always been a controversial subject. On the one hand, celebrity promotion enables millions of people to get awareness of the medication suitable for their existing health needs. On the other hand, celebrity promotion presents a set of regulatory and ethical problems that can cause detrimental harm by replacing professional medical advice with unscientific personal testimonials.

01 Sep 2023